Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
If you click a phishing link, act quickly: disconnect, scan devices, change passwords, and report the incident to protect your crypto assets.
17,697 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
A year of unprecedented cyber thefts saw North Korean-linked groups drain more than $2 billion from financial network...
Retirees face rising tax headwinds as withdrawals, Social Security, and Medicare premiums stack. A shift to proactive...
Greg Abel just sold Berkshire Hathaway's Visa and Mastercard holdings and started a new stake in a stock Warren Buffe...
Two entertainment giants, Netflix and Disney, are navigating a fast-changing landscape. This analysis breaks down rec...
A new Fed chair steps into a delicate mix of inflation pressures and a resilient job market. This guide breaks down c...
Gossamer Bio's 2026 earnings outlook centers on cash runway, pipeline progress, and strategic partnerships. This arti...
A sudden setback from a key launch partner has jolted AST SpaceMobile investors. This guide explains the causes, pote...
Burford kicks off 2026 with a solid Q1 showing that sheds light on the company’s revenue mix, profitability, and liqu...
Petco's WOOF ticker hints at a pet retailer balancing stores, services, and digital growth. This investor guide break...
This high-flying semiconductor stock has captured investors’ attention with AI-driven growth. It offers strong upside...
Medicare costs hinge on MAGI two years prior, making Roth withdrawals a strategic lever for retirees. New data show m...